When samples obtained at the time of hepatitis were compared with 12-week samples from controls, IgG antibodies against thyroglobulin were higher at the time of toxicity compared to baseline samples among those who developed hepatitis. The gene discussed is TG; the disease is hepatitis A virus infection.